2024

1. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

   Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211